Ignite Creation Date:
2025-12-25 @ 12:56 AM
Ignite Modification Date:
2026-05-28 @ 12:38 PM
Study NCT ID:
NCT06214793
Status:
SUSPENDED
Last Update Posted:
2025-05-01
First Post:
2024-01-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC)
Sponsor:
Megan Kruse, MD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CASE5123
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |